Bank of New York Mellon’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
145,117
+12,904
| +10% | +$225K | ﹤0.01% | 2627 |
|
|
2025
Q1 | $1.66M | Buy |
132,213
+1,975
| +2% | +$24.8K | ﹤0.01% | 2768 |
|
|
2024
Q4 | $1.37M | Sell |
130,238
-1,373
| -1% | -$14.5K | ﹤0.01% | 2938 |
|
|
2024
Q3 | $1.91M | Sell |
131,611
-7,674
| -6% | -$111K | ﹤0.01% | 2763 |
|
|
2024
Q2 | $1.19M | Buy |
139,285
+69,394
| +99% | +$591K | ﹤0.01% | 3092 |
|
|
2024
Q1 | $714K | Sell |
69,891
-14,467
| -17% | -$148K | ﹤0.01% | 3320 |
|
|
2023
Q4 | $462K | Buy |
84,358
+434
| +0.5% | +$2.38K | ﹤0.01% | 3594 |
|
|
2023
Q3 | $317K | Buy |
83,924
+7,024
| +9% | +$26.6K | ﹤0.01% | 3774 |
|
|
2023
Q2 | $515K | Buy |
76,900
+61,715
| +406% | +$413K | ﹤0.01% | 3567 |
|
|
2023
Q1 | $98.9K | Hold |
15,185
| – | – | ﹤0.01% | 4076 |
|
|
2022
Q4 | $130K | Buy |
+15,185
| New | +$130K | ﹤0.01% | 4078 |
|
|
2022
Q2 | – | Sell |
-58,644
| Closed | -$206K | – | 4690 |
|
|
2022
Q1 | $206K | Sell |
58,644
-1,417
| -2% | -$4.98K | ﹤0.01% | 4220 |
|
|
2021
Q4 | $400K | Buy |
60,061
+3,393
| +6% | +$22.6K | ﹤0.01% | 3934 |
|
|
2021
Q3 | $566K | Buy |
56,668
+17,124
| +43% | +$171K | ﹤0.01% | 3738 |
|
|
2021
Q2 | $1.22M | Buy |
39,544
+4,732
| +14% | +$146K | ﹤0.01% | 3283 |
|
|
2021
Q1 | $1.52M | Buy |
+34,812
| New | +$1.52M | ﹤0.01% | 3082 |
|